News Roundup: EUA Pfizer Booster for Teens, Contraceptive Program
Here’s a roundup of the latest news from Drug Topics®.
Breaking: FDA Amends Pfizer-BioNTech COVID-19 Vaccine EUA to Allow Booster Doses for Adolescents
Individuals aged 16 or 17 years may now receive a single booster dose at least 6 months after completion of their primary vaccination series.
Addition of Pharmacists to Diabetes Management Teams Enhances Care
The addition of a pharmacist to a diabetes management team increases therapy optimization and medication access while enhancing patient care
https://www.drugtopics.com/view/addition-of-pharmacists-to-diabetes-management-teams-enhances-care
ThoughtSpot 2021: Global Independent Pharmacy Trends
As part of our ThoughtSpot 2021 podcast series, guest host Jenni Zilka, President of Good Neighbor Pharmacy, leads a conversation on global trends in independent pharmacy across the US and Europe.
https://www.drugtopics.com/view/thoughtspot-2021-global-independent-pharmacy-trends
Update: 2021-2022 Flu Season
Influenza is expected to make a comeback this year, and no one knows how severe it may be.
https://www.drugtopics.com/view/update-2021-2022-flu-season
Evaluating Analgesic Use During COVID-19
Mean days of therapy per 1000 patient-days were reduced across medication categories.
https://www.drugtopics.com/view/evaluating-analgesic-use-during-covid-19
Pharmacist Prescribed Contraceptive Access Program Successful
Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.
https://www.drugtopics.com/view/pharmacist-prescribed-contraceptive-access-program-successful
Study: Increasing Naloxone Access Improves Opioid Outcomes
Study findings presented at the 2021 ASHP Midyear Clinical Meeting & Exhibition revealed naloxone counseling can impact the opioid crisis through patient education.
https://www.drugtopics.com/view/study-increasing-naloxone-access-improves-opioid-outcomes
